◼ Archived
Business
🔮 holds
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
Sanofi's Sarclisa becomes the first cancer drug to receive FDA approval for delivery via a wearable on-body injector for multiple myeloma patients.